Objectives The acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis
is one of the main causes of high mortality in patients with COVID-19 (novel coronavirus …

Purpose Corticosteroids are now recommended for patients with severe COVID-19 including
those with COVID-related ARDS. This has generated renewed interest regarding whether …

Background Covid-19 disease is caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2). Although corticosteroids have shown some promising results in Covid-19 …

Background: Corticosteroid treatment is an effective and common therapeutic strategy for
various inflammatory lung pathologies and may be an effective treatment for coronavirus …

Objectives Efficacy and safety of corticosteroids in patients with 2019-nCoV (novel
coronavirus 2019) infection still are debated. Because large randomized clinical trials …

BACKGROUND Corticosteroids are widely used in patients with COVID 19, although their
benefit-to-risk ratio remains controversial. METHODS Patients with severe COVID-19 …

Despite the increasing evidence of the benefit of corticosteroids for the treatment of
moderate-severe coronavirus disease 2019 (COVID-19) patients, no data are available …

BACKGROUND: Very little direct evidence exists on use of corticosteroids in patients with
coronavirus disease 2019 (COVID-19). Indirect evidence from related conditions must …

Background Since its appearance in late 2019, infections caused by severe acute
respiratory syndrome coronavirus 2 have created unprecedented challenges for health …

Importance Effective therapies for patients with coronavirus disease 2019 (COVID-19) are
needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced …